Renflexis 100 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FM49E
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $46,005
Award facts
- Contract value 100% obligated
- $46,004.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $46,004.57 firm fixed-price delivery order to Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3) on January 29, 2026, for the supply of RENFLEXIS 100 mg vials, with a completion date of January 30, 2026. This non-competitive delivery order was placed under Amerisourcebergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle valued through December 2026. Amerisourcebergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems.
This delivery order is a child task order under the larger DLA pharmaceutical prime vendor contract, which enables Amerisourcebergen to supply a comprehensive range of pharmaceutical products, medical supplies, vaccines, and specialized healthcare commodities to support military healthcare programs worldwide. The parent company, Cencora, Inc. (doing business as Amerisourcebergen), holds the underlying IDC valued at $999,999,999.00 through December 2031 with the Defense Logistics Agency. RENFLEXIS is a biosimilar to Remicade used in treating various inflammatory and autoimmune conditions, making this order consistent with the company's portfolio of specialty medications supporting military treatment facilities and federal healthcare institutions.
Quick answers
Who was awarded contract SPE2DR26FM49E?
SPE2DR26FM49E was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FM49E worth?
The government has obligated $46,005 on SPE2DR26FM49E.
Is contract SPE2DR26FM49E an order under another contract?
Yes. SPE2DR26FM49E is a delivery order under SPE2DR25D2007, an indefinite delivery contract.
Was contract SPE2DR26FM49E competed?
The extent of competition for SPE2DR26FM49E was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award